Glaxosmithkline Biologicals Sa

Rainer Follador

Michael T Kowarik

Stefan Jochen Kemmler

Amirreza Faridmoayer

Fabio Serventi

Gerald Johann Posch

Gerd Martin Lipowsky

The disclosure provides synthetic (e.g. recombinant) pneumococcal saccharides comprising one or more repeat unit(s) →4)-β-D-Glcp-(1→4)-[Gro-(2→P→3)]-β-D-Galp-(1→4)-β-L-Rhap-(1→. Also provided are conjugates comprising a →4)-β-D-Glcp-(1→4)-[Gro-(2→P→3)]-β-D-Galp-(1→4)-β-L-Rhap-(1→, immunogenic compositions, vaccines and their use in preventing or treating infection by

Immunogenic composition

The disclosure provides synthetic (e.g. recombinant) pneumococcal saccharide comprising one or more repeat unit(s) &#x2192;4)-&#x3b2;-D-Glcp-(1&#x2192;3)-[[&#x3b1;-L-Rhap-(1&#x2192;2)]-[Gro-(2&#x2192;P&#x2192;3)]-&#x3b2;-D-Galp-(1&#x2192;4)]-&#x3b2;-L-Rhap-(1&#x2192;. Also provided are conjugates comprising a &#x2192;4)-&#x3b2;-D-Glcp-(1&#x2192;3)-[[&#x3b1;-L-Rhap-(1&#x2192;2)]-[Gro-(2&#x2192;P&#x2192;3)]-&#x3b2;-D-Galp-(1&#x2192;4)]-&#x3b2;-L-Rhap-(1&#x2192;, immunogenic compositions, vaccines and their use in preventing or treating infection by

The disclosure provides synthetic (e.g. recombinant) pneumococcal saccharides comprising one or more repeat unit(s) &#x2192;4)-&#x3b2;-D-Glcp-(1&#x2192;4)-[Gro-(2&#x2192;P&#x2192;3)]-&#x3b2;-D-Galp-(1&#x2192;4)-&#x3b2;-L-Rhap-(1&#x2192;. Also provided are conjugates comprising a &#x2192;4)-&#x3b2;-D-Glcp-(1&#x2192;4)-[Gro-(2&#x2192;P&#x2192;3)]-&#x3b2;-D-Galp-(1&#x2192;4)-&#x3b2;-L-Rhap-(1&#x2192;, immunogenic compositions, vaccines and their use in preventing or treating infection by

Growing community of inventors

Schlieren, Switzerland

Rainer Follador